MVIR — Medivir AB Share News
0.000.00%
Last trade - 00:00- SEK906.04m
- SEK763.34m
- SEK8.51m
Sweden's Medivir Q1 revenue rises, EBITDA loss narrows
Brief: Medivir Q1 Revenue SEK 1 Million
Brief: Medivir Recruits Patrik Norgren As New CFO
Brief: Medivir Chairman Buys SEK 679,381 Of Shares In Co
Brief: Medivir Does Not Propose Dividend For 2025
Sweden's Medivir posts Q4 revenue of SEK 5.5 mln
Brief: Medivir Q4 Revenue SEK 5.5 Million
Brief: Vetbiolix Announces Starts Study To Confirm Clinical Benefit With Vbx-1000
Brief: Medivir Raises SEK 45 Million In Directed Share Issue
Brief: Medivir EGM Elcts Anders Hallberg As Chairman Of Board
Brief: Medivir's CFO Magnus Christensen To Leave Company
Brief: Medivir's MIV-711 Granted Orphan Drug Designation By FDA
Brief: Medivir Publishes Disclosure Document For SEK 151 Mln Share Issue
Brief: Medivir Q3 Adjusted EBITDA SEK -12.9 Million
Brief: Medivir Enters Exclusive Licensing Agreement With Biosil
Brief: Medivir Announces Fully Guaranteed Rights Issue Of About SEK 151 Mln
Brief: Medivir Q2 Revenue SEK 1.5 Million
Brief: Medivir Receives Notice Of Allowance For Fostrox Plus Lenvatinib Combination Patent In Japan
Brief: Medivir Q1 Adjusted EBITDA SEK -12.6 Million